Heron Therapeutics HRTX
NASDAQ HRTX
$0.38 +0.02 (+6.21%)
As of: Oct 2, 2026 · 12:28 PM EDT

Heron Therapeutics (HRTX) Cash from Financing Activities (2010 - 2026)

Updated

Heron Therapeutics' Cash from Financing Activities came in at $82,000 for Q2 2026, down 89.5% from $781,000 a year earlier.

Analysis

Heron Therapeutics (HRTX) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Heron Therapeutics reported Cash from Financing Activities of $13.61 million, up 961.9% year-over-year; for FY2025, it came in at $14.43 million.

  • Cash from Financing Activities carries a five-year compound annual growth rate of 9.6% (FY2020 to FY2025).
  • Going back by year, Cash from Financing Activities was $940,000 in FY2024 (-98.3%), $54.11 million in FY2023 (-27.9%), $75.06 million in FY2022 (-51.9%) and $156.03 million in FY2021.
  • The five-year range for quarterly Cash from Financing Activities is -$637,000 (Q1 2022) to $74.94 million (Q3 2022).
  • Year-over-year, Cash from Financing Activities increased in three of the last six quarters, with growth averaging 69.2%.
  • The fastest year-over-year change in Cash from Financing Activities over five years came in Q1 2025 (growth of 481.8%), and the weakest in Q3 2024 (a decline of 100.0%).
  • Business Quant data shows HRTX's Cash from Financing Activities at -$51,000 (Q1 2026), $219,000 (Q4 2025) and $13.36 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Heron Therapeutics 58.85 Mn -130.71 Mn 26.09 Mn 82,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 82,000.00
Mar 31, 2026 -51,000.00
Dec 31, 2025 219,000.00
Sep 30, 2025 13.36 Mn
Jun 30, 2025 781,000.00
Mar 31, 2025 64,000.00
Dec 31, 2024 423,000.00
Sep 30, 2024 14,000.00
Jun 30, 2024 492,000.00
Mar 31, 2024 11,000.00
Dec 31, 2023 199,000.00
Sep 30, 2023 53.80 Mn
Jun 30, 2023 319,000.00
Mar 31, 2023 -208,000.00
Dec 31, 2022 439,000.00
Sep 30, 2022 74.94 Mn
Jun 30, 2022 315,000.00
Mar 31, 2022 -637,000.00
Dec 31, 2021 487,000.00
Sep 30, 2021 -71,000.00
API Access

Heron Therapeutics Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=HRTX&period=max&api_key=YOUR_API_KEY